secwatch.observer — SEC 8-K summary
======================================

Issuer:     Precipio, Inc. (PRPO)
CIK:        0001043961
Form:       8-K
Filed at:   2023-12-14T23:59:59+00:00
Accession:  0001104659-23-126061
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precipio achieves two of three 2023 goals; revenue up ~50% YoY, cash burn cut 60%
--------------------------------------------------------------------------------

- Pathology division hit $14M annualized revenue in Q3, meeting target #1; product target lowered to $6M.
- Quarterly cash burn reduced from $2.5M (Q3-2022) to $1M (Q3-2023), exceeding target #3.
- Q3 2023 total revenue $4.5M (50% YoY gain); annualized run-rate ~$18.5M.
- Expects Q4 2023 revenue $3.2-$3.5M, FY 2023 total ~$14.5M vs $9.8M in 2022.
- If ~50% growth continues, positive cash flow possible in H2 2024 at ~$30M annual run-rate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1043961/000110465923126061/0001104659-23-126061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1043961/000110465923126061/tm2332910d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-126061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer